QT
PMVP icon

Quantbot Technologies’s PMV Pharmaceuticals PMVP Stock Holding History

Quantbot Technologies’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,336
Closed -$9.07K – 1811
2024
Q1 		$9.07K Hold
5,336
– – ﹤0.01% 1461
2023
Q4 		$16.5K Buy
5,336
+870
+19% +$2.3K ﹤0.01% 1440
2023
Q3 		$27.4K Sell
4,466
-2,200
-33% -$15.1K ﹤0.01% 1322
2023
Q2 		$41.7K Sell
6,666
-10,634
-61% -$55.7K ﹤0.01% 1342
2023
Q1 		$82.5K Buy
17,300
+11,594
+203% +$81.6K 0.01% 1147
2022
Q4 		$49.6K Buy
+5,706
New +$60.8K ﹤0.01% 1307
2022
Q3 		– Sell
-1,856
Closed -$26K – 1979
2022
Q2 		$26K Buy
+1,856
New +$27K ﹤0.01% 1420
2022
Q1 		– Sell
-1,700
Closed -$39K – 1968
2021
Q4 		$39K Buy
+1,700
New +$41.1K ﹤0.01% 1094

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Quantbot Technologies's PMVP Position: Q2 2024 in Review

Quantbot Technologies sold out of PMV Pharmaceuticals (PMVP) in Q2 2024, closing a stake of 5,336 shares — an estimated $9.07K sold.

Quantbot Technologies first reported a position in PMVP in Q4 2021 and held it in 8 quarters. The position peaked at $82.5K in Q1 2023. 93 funds tracked by Wall St. Rank hold PMVP as of Q2 2024.

  • Quantbot Technologies reported no remaining PMV Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Quantbot Technologies sold 5,336 PMV Pharmaceuticals shares in Q2 2024, an estimated $9.07K.
  • Quantbot Technologies first reported a position in PMV Pharmaceuticals in Q4 2021 and held it in 8 quarters.
  • Quantbot Technologies's PMV Pharmaceuticals position peaked at $82.5K in Q1 2023.
  • 93 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2024.

Based on Quantbot Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.